Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,530 public trials 2,140 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Recruiting

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

NCT05489783

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Glioma, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Stem Cell Ophthalmology Treatment Study II

NCT03011541

Conditions
Abnormalities, Multiple, Age-Related Macular Degeneration, Autoimmune Diseases, +75 more
Locations
  • MD Stem Cells Westport, Connecticut, United States
  • MD Stem Cells Coral Springs, Florida, United States
  • MD Stem Cells Kobinia Med Vienna, Austria
  • The Saudi-German Hospital Dubai, United Arab Emirates
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

NCT07246941

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Hospital Britanico de Buenos Aires Ciudad Autonoma Bs As, Argentina
  • Westmead Hospital Westmead, New South Wales, Australia
  • Monash Health Clayton, Victoria, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Recruiting

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

NCT06192563

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Investigational Site Number: 002 Bologna, Italy
  • Investigational Site Number: 006 Brescia, Italy
  • Investigational Site Number: 004 Florence, Italy
  • Investigational Site Number: 001 Milan, Italy
View Trial Details
Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805

Conditions
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH), Acquired angioedema, Angioedema, +15 more
Locations
  • Study Site San Diego, California, United States
  • Study Site Walnut Creek, California, United States
  • Study Site St Louis, Missouri, United States
  • Study Site Hershey, Pennsylvania, United States
View all 32 locations
View Trial Details
Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

NCT05589714

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • University of Arkansas, Jones Eye Institute Little Rock, Arkansas, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Health Jacksonville Jacksonville, Florida, United States
View all 36 locations
View Trial Details

Related conditions